[Peptides as inhibitors of thrombin coagulation activity and of thrombocyte aggregation].
The analysis of literature and our own data of regulatory peptides influence on the blood coagulation system is presenting. Various natural and synthetic peptides inhibit the activity of thrombin and platelet aggregation. Direct specific inhibitors of thrombin are peptides developed on the base of D-Phe-Pro-Arg sequence. Strong specific inhibitors of the prothrombinase complex factor Xa were isolated from tissues and saliva of the blood-sucking organisms. These inhibitors decrease thrombin generation at the early stage of blood coagulation cascade Anticoagulating peptides from the tick Ornithodoros moubata tissue (TAP), the recombinant rTAP from the saliva glands of tick Ornithodoros savignyi and peptide with even greater anticoagulating activity from saliva glands of fly Glossina morsitans morsitans were isolated and characterised. For complete and reliable suppression of thrombus formation simultaneous administration of thrombin and platelet aggregation inhibitors is necessary. Main terminal stage of platelet aggregation is the interaction of receptor GP IIb/IIIa with adhesive fibrinogen sequence Arg-Pro-Asp (RGD). Peptides derived on the base of this sequence compete with fibrinogen in reaction with platelet receptors. A lot of corresponding peptidomimetics were synthesised, e.g. MK-852, RO-44 and particularly effective compound integrelin. Many direct platelet aggregation inhibitors were found in snake venoms. Recombinant peptide TAP mentioned above exerts both antithrombin and antiaggregation activity. Peptides and peptide mimetics of this type rapidly and irreversibly bound with receptor GP IIb/IIIa. They have short half life time in the blood plasma. Their preference in comparison with other drugs is particularly rapid and strong action. In our experiments it was demonstrated, that simple proline-containing peptides Pro-Gly, Trp-Pro, Pro-Gly-Pro (putative fragments of collagen and elastin) possesses significant antithrombotic and anticoagulant potential in vitro and in in vivo. Perhaps these peptides are members on intrinsic complex of haemostasis regulators.
Pastorova
V E
VE
Biological Faculty, Moscow M. V. Lomonosov State University.
Liapina
L A
LA
Cherkasova
K A
KA
Ashmarin
I P
IP
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects* / Q000502:physiology; D005337:Fibrin / Q000187:drug effects / Q000502:physiology; D005343:Fibrinolytic Agents / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology / Q000502:physiology*; D010974:Platelet Aggregation / Q000187:drug effects* / Q000502:physiology; D013917:Thrombin / Q000037:antagonists & inhibitors* / Q000187:drug effects / Q000502:physiology
D005343:Fibrinolytic Agents; D010455:Peptides; D005337:Fibrin; D013917:Thrombin
Peptidy kak ingibitory svertyvaiushcheĭ aktivnosti trombina i agregatsii trombotsitov.